{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:12:23Z","timestamp":1753891943355,"version":"3.41.2"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,8,2]],"date-time":"2021-08-02T00:00:00Z","timestamp":1627862400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p><jats:bold>Introduction:<\/jats:bold>The spread of Covid-19 has worsened the prognosis of oncology patients, interrupting or delaying life-saving therapies and contextually increasing the risk of severe SARS-CoV-2 infections. Acute lymphoblastic leukemia (ALL) is the most frequent cancer in pediatric age and the management of this disease with concomitant SARS-COV-2 infection represents a challenging situation.<\/jats:p><jats:p><jats:bold>Case presentation:<\/jats:bold>We present the case of a 6-year-old female newly diagnosed with ALL during a documented SARS-CoV-2 infection. Our patient was admitted 20 days after SARS-CoV-2 detection for evening-rise fever. Laboratory testing showed severe neutropenia while chest x-ray detected moderate pulmonary involvement. Acute lymphoblastic leukemia diagnosis was made through morphological and molecular analysis on bone marrow aspirate. Given the stability of the blood count and clinical conditions, antiviral therapy with Remdesivir and Convalescent Plasma was started before antileukemic treatment, obtaining a rapid resolution of the infection.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold>In our experience, the treatment with Remdesivir and Convalescent Plasma led to a rapid resolution of Sars-Cov-2 infection. Our case did not present any adverse event to the therapy. Thus, this treatment could be considered in patients with malignancies, in order to accelerate the resolution of the infection and begin immunosuppressive treatment safely. Further studies are required to confirm this hypothesis.<\/jats:p>","DOI":"10.3389\/fped.2021.712603","type":"journal-article","created":{"date-parts":[[2021,8,2]],"date-time":"2021-08-02T07:28:02Z","timestamp":1627889282000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Case Report: Remdesivir and Convalescent Plasma in a Newly Acute B Lymphoblastic Leukemia Diagnosis With Concomitant Sars-CoV-2 Infection"],"prefix":"10.3389","volume":"9","author":[{"given":"Giovanni Battista","family":"Dell'Isola","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo","family":"Felicioni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi","family":"Ferraro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilaria","family":"Capolsini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla","family":"Cerri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grazia","family":"Gurdo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Mastrodicasa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Speranza","family":"Massei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katia","family":"Perruccio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariangela","family":"Brogna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Mercuri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara Luciani","family":"Pasqua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Gorello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizio","family":"Caniglia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Verrotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Arcioni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,8,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e28400","DOI":"10.1002\/pbc.28400","article-title":"COVID-19 and childhood acute lymphoblastic leukemia","volume":"67","author":"Taub","year":"2020","journal-title":"Pediatr Blood Cancer."},{"key":"B2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41416-020-0843-5","article-title":"Caring for our cancer patients in the wake of COVID-19","volume":"123","author":"El-Shakankery","year":"2020","journal-title":"Br J Cancer."},{"key":"B3","doi-asserted-by":"publisher","first-page":"e28432","DOI":"10.1002\/pbc.28432","article-title":"Severe COVID-19 disease in two pediatric oncology patients","volume":"67","author":"Stokes","year":"2020","journal-title":"Pediatr Blood Cancer."},{"key":"B4","first-page":"1787","article-title":"SARS-CoV-2 infection in an adolescent after haploidentical stem cell transplantation","volume":"6","author":"Massei","year":"2021","journal-title":"Clin Oncol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"e28327","DOI":"10.1002\/pbc.28327","article-title":"Early advice on managing children with cancer during the COVID-19 pandemic and a call for sharing experiences","volume":"67","author":"Bouffet","year":"2020","journal-title":"Pediatr Blood Cancer."},{"key":"B6","doi-asserted-by":"publisher","first-page":"e28727","DOI":"10.1002\/pbc.28727","article-title":"Comment on: acute lymphoblastic leukemia onset in a 3-year-old child with COVID-19","volume":"68","author":"Colaiacovo","year":"2021","journal-title":"Pediatr Blood Cancer."},{"key":"B7","doi-asserted-by":"publisher","first-page":"e28423","DOI":"10.1002\/pbc.28423","article-title":"Acute lymphoblastic leukemia onset in a 3-year-old child with COVID-19","volume":"67","author":"Marcia","year":"2020","journal-title":"Pediatr Blood Cancer."},{"key":"B8","doi-asserted-by":"publisher","first-page":"e274","DOI":"10.1111\/bjh.17014","article-title":"Remdesivir during induction chemotherapy for newly diagnosed paediatric acute lymphoblastic leukaemia with concomitant SARS-CoV-2 infection","volume":"190","author":"Orf","year":"2020","journal-title":"Br J Haematol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"4358","DOI":"10.1182\/bloodadvances.2020002745","article-title":"Successful management of SARS-CoV-2 acute respiratory distress syndrome and newly diagnosed acute lymphoblastic leukemia","volume":"4","author":"Phillips","year":"2020","journal-title":"Blood Adv."},{"key":"B10","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1093\/jpids\/piaa115","article-title":"Multicenter interim guidance on use of antivirals for children with Coronavirus Disease 2019\/Severe acute respiratory syndrome coronavirus 2","volume":"10","author":"Chiotos","year":"2021","journal-title":"J Pediatric Infect Dis Soc."},{"key":"B11","doi-asserted-by":"publisher","first-page":"e28693","DOI":"10.1002\/pbc.28693","article-title":"Convalescent plasma for pediatric patients with SARS-CoV-2-associated acute respiratory distress syndrome","volume":"67","author":"Diorio","year":"2020","journal-title":"Pediatr Blood Cancer."},{"key":"B12","first-page":"202","article-title":"Med Lett Drugs Ther","volume":"62","author":"An","year":"2020"},{"key":"B13","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1093\/jpids\/piaa175","article-title":"Initial guidance on use of monoclonal antibody therapy for treatment of Coronavirus disease 2019 in children and adolescents","volume":"10","author":"Wolf","year":"2021","journal-title":"J Pediatric Infect Dis Soc."},{"article-title":"All 2017, International Collaborative Treatment Protocol for Children and Adolescents With Acute Lymphoblastic Leukemia","volume-title":"A Randomized Phase III Study Conducted by the AIEOP-BFM Study Group","year":"2017","key":"B14"},{"key":"B15","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/S1470-2045(20)30096-6","article-title":"Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China","volume":"21","author":"Liang","year":"2020","journal-title":"Lancet Oncol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"102983","DOI":"10.1016\/j.transci.2020.102983","article-title":"SARS-CoV-2 convalescent plasma therapy in pediatric patient after hematopoietic stem cell transplantation","volume":"60","author":"Balashov","year":"2021","journal-title":"Transfus Apher Sci."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1007\/s00431-020-03683-8","article-title":"Characteristic of COVID-19 infection in pediatric patients: early findings from two Italian pediatric research networks","volume":"179","author":"Parri","year":"2020","journal-title":"Eur J Pediatr."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1056\/NEJMoa2031893","article-title":"Convalescent plasma antibody levels and the risk of death from covid-19","volume":"384","author":"Joyner","year":"2021","journal-title":"N Engl J Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s13312-021-2110-0","article-title":"Successful convalescent plasma therapy in a child with severe Coronavirus disease","volume":"58","author":"Das","year":"2021","journal-title":"Indian Pediatr."},{"key":"B20","doi-asserted-by":"publisher","first-page":"102866","DOI":"10.1016\/j.transci.2020.102866","article-title":"First case of convalescent plasma transfusion in a child with COVID-19-associated severe aplastic anemia","volume":"59","author":"Figlerowicz","year":"2020","journal-title":"Transfus Apher Sci."},{"key":"B21","doi-asserted-by":"publisher","first-page":"4278","DOI":"10.1182\/bloodadvances.2020002507","article-title":"COVID-19 convalescent plasma clears SARS-CoV-2 refractory to remdesivir in an infant with congenital heart disease","volume":"4","author":"Rodriguez","year":"2020","journal-title":"Blood Adv."},{"key":"B22","doi-asserted-by":"publisher","first-page":"102956","DOI":"10.1016\/j.transci.2020.102956","article-title":"Convalescent plasma to aid in recovery of COVID-19 pneumonia in a child with acute lymphoblastic leukemia","volume":"60","author":"Shankar","year":"2021","journal-title":"Transfus Apher Sci."},{"key":"B23","doi-asserted-by":"crossref","DOI":"10.1016\/j.chom.2021.04.007","article-title":"Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization","volume-title":"bioRxiv.","author":"Wang","year":"2021"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e283","DOI":"10.1016\/S2666-5247(21)00068-9","article-title":"SARS-CoV-2 spike E484K mutation reduces antibody neutralisation","volume":"2","author":"Jangra","year":"2021","journal-title":"Lancet Microbe."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1016\/j.cell.2021.03.013","article-title":"Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity","volume":"184","author":"Garcia-Beltran","year":"2021","journal-title":"Cell"},{"key":"B26","unstructured":"Fact Sheet for Healthcare Providers: Emergency Use Authorization (EUA) of Remdesivir (GS-5734)"},{"key":"B27","doi-asserted-by":"publisher","first-page":"2663","DOI":"10.1093\/cid\/ciaa638","article-title":"Predicting infectious severe acute respiratory syndrome coronavirus 2 from diagnostic samples","volume":"71","author":"Bullard","year":"2020","journal-title":"Clin Infect Dis."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/S2213-2600(20)30453-7","article-title":"False-positive COVID-19 results: hidden problems and costs","volume":"8","author":"Surkova","year":"2020","journal-title":"Lancet Respir Med."}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2021.712603\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T03:52:11Z","timestamp":1672977131000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2021.712603\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,2]]},"references-count":28,"alternative-id":["10.3389\/fped.2021.712603"],"URL":"https:\/\/doi.org\/10.3389\/fped.2021.712603","relation":{},"ISSN":["2296-2360"],"issn-type":[{"type":"electronic","value":"2296-2360"}],"subject":[],"published":{"date-parts":[[2021,8,2]]},"article-number":"712603"}}